130 related articles for article (PubMed ID: 36007392)
1. Mesenchymal stem cell transplantation alleviates Sjögren's syndrome symptoms by modulating Tim-3 expression.
Sun T; Liu S; Yang G; Zhu R; Li Z; Yao G; Chen H; Sun L
Int Immunopharmacol; 2022 Oct; 111():109152. PubMed ID: 36007392
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
[No Abstract] [Full Text] [Related]
4. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
7. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
Li B; Xing Y; Gan Y; He J; Hua H
Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.
Xu J; Wang D; Liu D; Fan Z; Zhang H; Liu O; Ding G; Gao R; Zhang C; Ding Y; Bromberg JS; Chen W; Sun L; Wang S
Blood; 2012 Oct; 120(15):3142-51. PubMed ID: 22927248
[TBL] [Abstract][Full Text] [Related]
9. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells.
Rui K; Hong Y; Zhu Q; Shi X; Xiao F; Fu H; Yin Q; Xing Y; Wu X; Kong X; Xu H; Tian J; Wang S; Lu L
Cell Mol Immunol; 2021 Feb; 18(2):440-451. PubMed ID: 33408339
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review.
Chihaby N; Orliaguet M; Le Pottier L; Pers JO; Boisramé S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638813
[TBL] [Abstract][Full Text] [Related]
11. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord mesenchymal stem cells alleviate Sjögren's syndrome and related pulmonary inflammation through regulating Vγ4
Cong Y; Tang X; Wang D; Zhang Z; Huang S; Zhang X; Yao G; Sun L
Ann Transl Med; 2022 May; 10(10):594. PubMed ID: 35722394
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.
Abughanam G; Elkashty OA; Liu Y; Bakkar MO; Tran SD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557796
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
Tian J; Hong Y; Zhu Q; Zhou H; Zhang Y; Shen Z; Guo H; Zhang Y; Ai X; Zhao F; Rui K; Xu H; Wang S
Front Immunol; 2020; 11():604607. PubMed ID: 33414787
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
[TBL] [Abstract][Full Text] [Related]
16. Targeting EZH2 prevents the occurrence and mitigates the development of Sjögren's syndrome in mice.
Zhu S; Liu M; Zhu F; Yu X; Wen J; Li C
Int Immunopharmacol; 2022 Sep; 110():109073. PubMed ID: 35978516
[TBL] [Abstract][Full Text] [Related]
17. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
[TBL] [Abstract][Full Text] [Related]
18. Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren's syndrome.
Hu L; Xu J; Wu T; Fan Z; Sun L; Liu Y; Li Y; Zhang C; Wang J; Ding Y; Wang S
Cell Death Dis; 2020 Mar; 11(3):172. PubMed ID: 32139667
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
20. Compact Bone-Derived Multipotent Mesenchymal Stromal Cells (MSCs) for the Treatment of Sjogren's-like Disease in NOD Mice.
Elghanam GA; Liu Y; Khalili S; Fang D; Tran SD
Methods Mol Biol; 2017; 1553():25-39. PubMed ID: 28229405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
